Literature DB >> 23107104

Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.

J W Mays1, H Fassil, D A Edwards, S Z Pavletic, C W Bassim.   

Abstract

Optimal management of complex autoimmune diseases requires a multidisciplinary medical team including dentists to care for lesions of the oral cavity. In this review, we discuss the presentation, prevalence, diagnosis, and treatment of oral manifestations in chronic graft-versus-host disease (cGVHD), which is a major late complication in patients treated by allogeneic hematopoietic stem cell transplantation. We assess current general knowledge of systemic and oral cGVHD and present general treatment recommendations based on literature review and our clinical experience. Additionally, we review areas where the understanding of oral cGVHD could be improved by further research and address tools with which to accomplish the long-term goal of providing better health and quality of life to patients with cGVHD. Published 2012. This article is a US Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23107104      PMCID: PMC3561479          DOI: 10.1111/odi.12028

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  109 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

2.  Response of oral lichen planus to topical tacrolimus in 37 patients.

Authors:  Julie A Byrd; Mark D P Davis; Alison J Bruce; Lisa A Drage; Roy S Rogers
Journal:  Arch Dermatol       Date:  2004-12

3.  Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Whitney S Washel; Nazmim S Bhuiya; Corey S Cutler; Edwin P Alyea; Vincent T Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2010-11-19       Impact factor: 22.113

4.  The significance of oral mucosal and salivary gland pathology after allogeneic bone marrow transplantation.

Authors:  T D Horn; E B Rest; Y Mirenski; R L Corio; M L Zahurak; G B Vogelsang
Journal:  Arch Dermatol       Date:  1995-08

5.  Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.

Authors:  Kevin She; Andrew L Gilman; Soudabeh Aslanian; Hiromi Shimizu; Mark Krailo; Zhengjia Chen; Gregor S Reid; Donna Wall; Fred Goldman; Kirk R Schultz
Journal:  Biol Blood Marrow Transplant       Date:  2007-02-15       Impact factor: 5.742

Review 6.  The IL-17 differentiation pathway and its role in transplant outcome.

Authors:  Jonathan S Serody; Geoffrey R Hill
Journal:  Biol Blood Marrow Transplant       Date:  2012-01       Impact factor: 5.742

7.  A new murine model for bronchiolitis obliterans post-bone marrow transplant.

Authors:  Angela Panoskaltsis-Mortari; Kevin V Tram; Andrew P Price; Christine H Wendt; Bruce R Blazar
Journal:  Am J Respir Crit Care Med       Date:  2007-06-15       Impact factor: 21.405

8.  Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group.

Authors:  Hisaki Fujii; Geoff Cuvelier; Kevin She; Soudabeh Aslanian; Hiromi Shimizu; Amina Kariminia; Mark Krailo; Zhengjia Chen; Rob McMaster; Axel Bergman; Frederick Goldman; Stephen A Grupp; Donna A Wall; Andrew L Gilman; Kirk R Schultz
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

9.  Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.

Authors:  Sibel Koc; Wendy Leisenring; Mary E D Flowers; Claudio Anasetti; H Joachim Deeg; Richard A Nash; Jean E Sanders; Robert P Witherspoon; Rainer Storb; Frederick R Appelbaum; Paul J Martin
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

10.  Oral epithelial dysplasia and squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: clinical presentation and treatment outcomes.

Authors:  H Mawardi; S Elad; M E Correa; K Stevenson; S-B Woo; S Almazrooa; R Haddad; J H Antin; R Soiffer; N Treister
Journal:  Bone Marrow Transplant       Date:  2011-04-04       Impact factor: 5.483

View more
  28 in total

1.  Validation of the National Institutes of Health chronic GVHD Oral Mucosal Score using component-specific measures.

Authors:  C W Bassim; H Fassil; J W Mays; D Edwards; K Baird; S M Steinberg; K M Williams; E W Cowen; S A Mitchell; K Cole; T Taylor; D Avila; D Zhang; D Pulanic; L Grkovic; D Fowler; R E Gress; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2013-09-02       Impact factor: 5.483

Review 2.  Oral Complications of Chronic Graft-Versus-Host Disease.

Authors:  Jane M Fall-Dickson; Steven Z Pavletic; Jacqueline W Mays; Mark M Schubert
Journal:  J Natl Cancer Inst Monogr       Date:  2019-08-01

3.  Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers.

Authors:  Sharon Elad; Siri Beier Jensen; Judith E Raber-Durlacher; Nancy Mouradian; Elvira M P Correa; Mark M Schubert; Nicole M A Blijlevens; Joel B Epstein; Deborah P Saunders; Tuomas Waltimo; Noam Yarom; Yehuda Zadik; Michael T Brennan
Journal:  Support Care Cancer       Date:  2014-11-23       Impact factor: 3.603

Review 4.  Oral lichenoid lesions: distinguishing the benign from the deadly.

Authors:  Susan Müller
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

5.  Regression of oral proliferative leukoplakia following initiation of ibrutinib therapy in two allogeneic hematopoietic stem cell transplant recipients.

Authors:  Paolo J Fantozzi; Alessandro Villa; Joseph H Antin; Nathaniel Treister
Journal:  Bone Marrow Transplant       Date:  2020-04-09       Impact factor: 5.483

6.  Oral disease profiles in chronic graft versus host disease.

Authors:  C W Bassim; H Fassil; J W Mays; D Edwards; K Baird; S M Steinberg; E W Cowen; H Naik; M Datiles; P Stratton; R E Gress; S Z Pavletic
Journal:  J Dent Res       Date:  2015-03-04       Impact factor: 6.116

Review 7.  Oral and dental late effects in survivors of childhood cancer: a Children's Oncology Group report.

Authors:  Karen E Effinger; Cesar A Migliorati; Melissa M Hudson; Kevin P McMullen; Sue C Kaste; Kathy Ruble; Gregory M T Guilcher; Ami J Shah; Sharon M Castellino
Journal:  Support Care Cancer       Date:  2014-04-30       Impact factor: 3.603

8.  Autologous blood as a source of platelet gel for the effective and safe treatment of oral chronic graft-versus-host disease.

Authors:  Ines Bojanic; Marinka Mravak Stipetic; Drazen Pulanic; Lana Desnica; Sanja Mazic; Branka Golubic Cepulic; Ranka Serventi Seiwerth; Radovan Vrhovac; Damir Nemet; Steven Z Pavletic
Journal:  Transfusion       Date:  2018-03-14       Impact factor: 3.157

Review 9.  Graft-versus-host disease (GvHD) of the tongue and of the oral cavity: a large retrospective study.

Authors:  Andrea Piccin; Mario Tagnin; Cinzia Vecchiato; Ahmad Al-Khaffaf; Lisa Beqiri; Caroline Kaiser; Iris Agreiter; Giovanni Negri; Michael Kob; Angela Di Pierro; Fabio Vittadello; Guido Mazzoleni; Klaus Eisendle; Fabrizio Fontanella
Journal:  Int J Hematol       Date:  2018-08-24       Impact factor: 2.490

Review 10.  Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients.

Authors:  C Fiuza-Luces; R J Simpson; M Ramírez; A Lucia; N A Berger
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.